Conversion of Twice-Daily Tacrolimus to Once-Daily Tacrolimus Formulation in Stable Pediatric Kidney Transplant Recipients: Pharmacokinetics and Efficacy
Article first published online: 4 JUN 2013
© Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 13, Issue 8, pages 2191–2197, August 2013
How to Cite
Min, S. I., Ha, J., Kang, H. G., Ahn, S., Park, T., Park, D. D., Kim, S. M., Hong, H. J., Min, S. K., Ha, I. S. and Kim, S. J. (2013), Conversion of Twice-Daily Tacrolimus to Once-Daily Tacrolimus Formulation in Stable Pediatric Kidney Transplant Recipients: Pharmacokinetics and Efficacy. American Journal of Transplantation, 13: 2191–2197. doi: 10.1111/ajt.12274
- Issue published online: 26 JUL 2013
- Article first published online: 4 JUN 2013
- Manuscript Accepted: 31 MAR 2013
- Manuscript Revised: 29 MAR 2013
- Manuscript Received: 30 JAN 2013
Additional Supporting Information may be found in the online version of this article.
Figure S1. Changes of pharmacokinetic parameters after 1:1 based conversion in individual cases.
Figure S2. Correlation of AUC0–24 and Cmin for Days 7, 14 and 28.
Table S1. Results of modified immunosuppressant therapy barrier scale (ITBS) survey
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.